Clincosm LogoSign in Get a demo

Osteopenia

Showing NaN - NaN of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV/AIDS, HIV-1-infection, Osteopenia Trial in United States (Dolutegravir (DTG) 50MG/lamivudine (3TC) 300MG FIXED DOSE

Withdrawn
  • HIV/AIDS
  • +2 more
  • Dolutegravir (DTG) 50MG/lamivudine (3TC) 300MG FIXED DOSE COMBINATION (FDC)
  • Current tenofovir alafenamide (TAF)-containing ART regimen
  • Birmingham, Alabama
  • +9 more
Mar 10, 2021

Cancer, Cataract, Low Bone Mineral Density Trial in Worldwide (Denosumab, Placebo)

Completed
Has Results
  • Cancer
  • +5 more
  • Denosumab
  • Placebo
  • Anaheim, California
  • +171 more
Apr 19, 2017

Primary Hyperparathyroidism, Hypercalcemia, Vitamin D Deficiency Trial in New York (Placebo, Vitamin D3)

Withdrawn
  • Primary Hyperparathyroidism
  • +4 more
  • Placebo
  • Vitamin D3
  • New York, New York
    Columbia University Medical Center
Mar 4, 2015

Physical and Metabolic Abnormalities in HIV Infected and

Completed
  • HIV Infections
  • +6 more
    • Birmingham, Alabama
    • +37 more
    Jan 6, 2014